RZ
Therapeutic Areas
HOOKIPA Pharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| HB-200 (Eseba-vec) | HPV16+ recurrent/metastatic Head and Neck Cancer | Phase 2 |
| HB-300 | KRAS-mutated advanced solid tumors | Phase 1/2 |
| HB-500 | HIV (Therapeutic) | Preclinical |
| HB-700 | Cytomegalovirus (CMV) Prophylactic Vaccine | Preclinical |
| Gilead Partnership Program | HIV (Therapeutic) | Phase 1 |
Leadership Team at HOOKIPA Pharma
MP
Malte Peters
Chief Executive Officer
TC
Terry Coelho
Executive Vice President & Chief Financial Officer
MW
Mark Winderlich
Chief Research & Development Officer
AB
Andreas Bergthaler
Co-Founder
LF
Lukas Flatz
Co-Founder
DP
Daniel Pinschewer
Co-Founder